𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Eicosanoid production by the mucosa in inflammatory bowel disease after 5-ASA treatment

✍ Scribed by F. J. Zijlstra; A. P. M. van Dijk; R. J. Th. Ouwendijk; I. C. van Riemsdijk-Overbeeke; J. H. P. Wilson

Publisher
SP Birkhäuser Verlag Basel
Year
1993
Tongue
English
Weight
167 KB
Volume
38
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Butyrate utilization by the colonic muco
Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency
✍ Ronan Thibault; François Blachier; Béatrice Darcy-Vrillon; Pierre de Coppet; Arn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

The short-chain fatty acid butyrate, which is mainly produced in the lumen of the large intestine by the fermentation of dietary fibers, plays a major role in the physiology of the colonic mucosa. It is also the major energy source for the colonocyte. Numerous studies have reported that butyrate met

Balancing inflammatory, lipid, and xenob
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease
✍ C. Reiff; M. Delday; G. Rucklidge; M. Reid; G. Duncan; S. Wohlgemuth; G. Hörmann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

## Background: The interleukin 10 knockout mouse (IL10-KO) is a model of human inflammatory bowel disease (IBD) used to study host microbial interactions and the action of potential therapeutics. Using Affymetrix data analysis, important signaling pathways and transcription factors relevant to gut